I think it's foolish to say they won't dilute. If nothing else, I believe corporate officer's are taking very little, or no salaries, but getting stock routinely.
It's possible that Mediq is paying for the trials they indicated should be run, but if not, I would expect some dilution would be needed to pay for those trials.
Multiple Myeloma treatment will almost certainly require full FDA type trials, and they won't be cheap. If OWCP partners the drug before they initiate such trials dilution may not be needed, but if they really want to capitalize on the drug I believe the least they'd want to show a potential partner is efficacy, and that can only be established by running at least a Phase 1/2 Trial. If this is done at Sheba, perhaps the cost won't be excessive, but these things can't be done for free.
Companies like OWCP exist because of dilution until a revenue stream is created. Even after substantial annual revenue is established, if the company determines they'd like to keep a bigger piece of the pie, they may need to dilute in order to afford the production facility for new products they've developed. Once they have production, they may choose to handle distribution and sales in at least a part of the world, that too adds costs, but over time the profits grow far faster.
Of course dilution is relative, today if they need a million they'd need to issue 3 million or more shares. Perhaps a year from now if they need a million, just 100K shares would be needed. Clinical trials can run into the hundreds of millions if you take a drug through the entire three phases required by the FDA in most cases. While I believe they want to partner their products today, I'm really uncertain that such partnerships will occur before solid proof exists that approvals are in the cards.
Of course if you approach the products as neutraceuticals or cosmetics the costs are greatly diminished, but the company seems to be emphasizing they're desire to create cannabis based drugs.
Frankly I don't know if any insurance covers things like Co-Q-10, Fish Oil, or many other nutraceutical products that many Doctor's suggest to their patients. I suspect that many people with good drug insurance pay more for nutraceuticals than they pay for all their prescription drugs. Any trip to Costco or CVS reveals a myriad of products claiming to have all sorts of benefits with little proof, yet sales go into the billions.
Gary
News 
Market Data 
Discover 
